Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Pilz, Stefan [VerfasserIn]   i
 Tomaschitz, Andreas [VerfasserIn]   i
 Meinitzer, Andreas [VerfasserIn]   i
 Drechsler, Christiane [VerfasserIn]   i
 Ritz, Eberhard [VerfasserIn]   i
 Krane, Vera [VerfasserIn]   i
 Wanner, Christoph [VerfasserIn]   i
 Böhm, Bernhard O. [VerfasserIn]   i
 März, Winfried [VerfasserIn]   i
Titel:Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography
Verf.angabe:Stefan Pilz MD, Andreas Tomaschitz MD, Andreas Meinitzer PhD, Christiane Drechsler MD, PhD,Eberhard Ritz MD, Vera Krane MD, Christoph Wanner MD, Bernhard O. Böhm MD, Winfried März MD
E-Jahr:2011
Jahr:10 February 2011
Umfang:3 S.
Fussnoten:Gesehen am 15.12.2022
Titel Quelle:Enthalten in: Stroke
Ort Quelle:New York, NY : Association, 1970
Jahr Quelle:2011
Band/Heft Quelle:42(2011), 4, Seite 1132-1134
ISSN Quelle:1524-4628
Abstract:BACKGROUND AND PURPOSE: Low serum concentrations of the amino acid homoarginine have been associated with endothelial dysfunction and an increased risk of all-cause and cardiovascular mortality. We aimed to investigate whether homoarginine levels are also associated with fatal strokes and a history of nonfatal cerebrovascular disease. - METHODS: Serum homoarginine was measured in 3305 participants of the Ludwigshafen Risk and Cardiovascular Health (LURIC) study who were referred to coronary angiography at baseline (1997 to 2000) and were followed up with respect to mortality. - RESULTS: During a median follow-up time of 9.9 years, 991 patients died including 61 fatal (ischemic and hemorrhagic) strokes. In a binary logistic regression analysis, the odds ratio (with 95% CI) for fatal stroke per SD of homoarginine was 0.52 (0.37 to 0.73; P<0.001) and remained significant after multivariable adjustments (0.62 [0.42 to 0.91]; P=0.014). For previous cerebrovascular disease events, the multivariable adjusted OR per SD of homoarginine was 0.82 (0.70 to 0.96; P=0.014). - CONCLUSIONS: Low homoarginine levels are a novel risk factor for fatal strokes and are reduced in patients with a history of cerebrovascular disease. Further studies are needed to explore the significance of homoarginine to risk stratification and therapeutic approaches in the prevention of strokes.
DOI:doi:10.1161/STROKEAHA.110.603035
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1161/STROKEAHA.110.603035
 DOI: https://doi.org/10.1161/STROKEAHA.110.603035
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Aged
 Biomarkers
 Comorbidity
 Coronary Angiography
 Coronary Artery Disease
 Endothelial Cells
 Female
 Follow-Up Studies
 Homoarginine
 Humans
 Male
 Middle Aged
 Mortality
 Risk Factors
 Stroke
 Time Factors
K10plus-PPN:1827173939
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68997585   QR-Code
zum Seitenanfang